Device Surgical Stapling Device

Aeon Endostapler & Echelon Flex Powered Stapler

Payments companies reported to CMS as associated with Aeon Endostapler & Echelon Flex Powered Stapler. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$177Kassociated payments (2023-2025)
323clinicians with associated payments
1company reporting

By year

2023 $15K
2024 $67K
2025 $94K

Payments reported as associated with Aeon Endostapler & Echelon Flex Powered Stapler, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $129K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $30K
Colon & Rectal Surgery $2,400
Surgical Oncology $1,872
Urology $555
Primary Care $506

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aeon Endostapler & Echelon Flex Powered Stapler

These are the largest totals companies reported as associated with Aeon Endostapler & Echelon Flex Powered Stapler. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joshua Roller Fayetteville, AR Surgery $114,004.54
Dustin Walters Farmington, CT Thoracic Surgery (Cardiothoracic Vascular Surgery) $18,688.73
Helmuth Billy Zephyr Cove, NV $8,621.99
Nabil Munfakh Saint Louis, MO Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,179.10
Carlos Barba Brownsville, TX Surgery $548.50
Richard Novack Fort Worth, TX Surgery $545.62
Narciso Gomez Hollywood, FL Colon & Rectal Surgery $532.60
Richard Lazzaro Toms River, NJ Thoracic Surgery (Cardiothoracic Vascular Surgery) $528.70
Sandra Freeman Tampa, FL Primary Care $506.18
Iswanto Sucandy Tampa, FL Surgery $506.18

Prescribed Aeon Endostapler & Echelon Flex Powered Stapler?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.